- Home
- About
- Find staff
- Per Lindner
Per Lindner
Adjunct Professor
Department of Transplant Surgery-
Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT
study)
Lillian Streichart, Marie Felldin, Jana Ekberg, Lars Mjörnstedt, Per Lindner, Annette Lennerling, Verena Brocker, Johan Molne, Jan Holgersson, Kristien Daenen, Lars Wennberg, Tomas Lorant, Seema Baid-Agrawal
Trials - 2024 -
A phase Ib randomized multicenter trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab for uveal
melanoma
Roger Olofsson Bagge, Axel Nelson, A. Shafazand, Christian Cahlin, A. Carneiro, H. Helgadottir, Max Levin, Magnus Rizell, G. Ullenhag, S. Wiren, Per Lindner, Jonas A Nilsson, Lars Ny
ESMO OPEN - 2024 -
End-ischemic hypothermic oxygenated machine perfusion does not improve renal outcome following liver transplantation from aged donors: A single-center retrospective
report
Åsa Norén, Johan Mölne, William Bennet, Gustaf Sorensen, Gustaf Herlenius, Per Lindnér, Mihai Oltean
ARTIFICIAL ORGANS - 2023 -
Long and Short-Term Effects of Hypothermic Machine Perfusion vs. Cold Storage on Transplanted Kidneys from Expanded Criteria Donors-A Matched Comparison
Study
Matthias Axelsson, Per Lindner, Nils-Gunnar Pehrsson, Seema Baid-Agrawal
JOURNAL OF CLINICAL MEDICINE - 2023 -
Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM
Trial)
Roger Olofsson Bagge, Axel Nelson, A. Shafazand, C. All-Eriksson, Christian Cahlin, N. Elander, H. Helgadottir, J. F. Kiilgaard, S. Kinhult, I. Ljuslinder, J. Mattsson, Magnus Rizell, Malin Sternby Eilard, G. J. Ullenhag, Jonas A Nilsson, Lars Ny, Per Lindnér
Journal of Clinical Oncology - 2023 -
Heparin Conjugate Pretreatment of Kidneys From Deceased Donors Before Transplantation: Results From the First-in-human Randomized Phase I
Trial
A. Sedigh, T. Lundgren, Per Lindnér, J. Nordstrom, P. Magnusson, J. Jonsson, F. Carlsson, R. Ploeg, T. Lorant
Transplantation Direct - 2023 -
Scandiatransplant Exchange Program (STEP): Development and Results From an International Kidney Exchange
Program
I. D. Weinreich, T. Andersson, M. B. Andrésdóttir, M. Bengtsson, A. Biglarnia, C. Bistrup, L. Boulland, H. Bruunsgaard, I. Helanterä, K. Kölvald, J. Lauronen, J. P. Lindahl, K. Skov, S. S. Sorensen, L. Wennberg, Per Lindner
Transplantation Direct - 2023 -
A Randomized Controlled Trial on Safety of Steroid Avoidance in Immunologically Low-Risk Kidney Transplant
Recipients
Jana Ekberg, Seema Baid-Agrawal, B. Jespersen, R. Källén, E. Rafael, K. Skov, Per Lindnér
Kidney International Reports - 2022 -
SOULMATE: the Swedish study of liver transplantation for isolated colorectal cancer liver metastases not suitable for operation or ablation, compared to best established treatment-a randomized controlled multicenter
trial
Veronica Reivell, H. Hagman, J. Haux, C. Jorns, Per Lindnér, Helena Taflin
Trials - 2022 -
Effects of Corticosteroid Treatment on Mycophenolic Acid Exposure in Renal Transplant Patients—Results From the SAILOR
Study
Nima Nourbakhsh, Jana Ekberg, Karin Skov, Christian Daugaard Peters, Aygen Øzbay, Per Lindnér, Niels Henrik Buus
Frontiers in Pharmacology - 2021 -
Observational study of risk factors associated with clinical outcome among elderly kidney transplant recipients in Sweden - a decade of
follow-up
H. Erlandsson, A. R. Qureshi, T. Scholz, T. Lundgren, A. Bruchfeld, P. Stenvinkel, L. Wennberg, Per Lindnér
Transplant International - 2021 -
COVID-19 in solid organ transplant recipients: A national cohort study from
Sweden.
John M. Söfteland, Gustav Friman, Bengt von Zur-Mühlen, Bo-Göran Ericzon, Carin Wallquist, Kristjan Karason, Vanda Friman, Jan Ekelund, Marie Felldin, Jesper Magnusson, Ida Haugen Löfman, Andreas Schult, Emily de Coursey, Susannah Leach, Hanna Jacobsson, Jan-Åke Liljeqvist, Ali Reza Biglarnia, Per Lindnér, Mihai Oltean
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons - 2021 -
Checkpoint Inhibition Causing Complete Remission of Metastatic Combined Hepatocellular-Cholangiocarcinoma after Hepatic
Resection
Magnus Rizell, Fredrik Åberg, Mats Perman, Lars Ny, Liselotte Sten, Farida Hashimi, Joar Svanvik, Per Lindnér
Case Reports in Oncology - 2020 -
Presence of tumor-infiltrating CD8(+) T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver
metastasis
Junko Johansson, Jan Siarov, Roberta Kiffin, Johan Mölne, J. Mattsson, Peter Naredi, Roger Olofsson Bagge, Anna Martner, Per Lindnér
OncoImmunology - 2020 -
Molecular profiling of driver events in metastatic uveal
melanoma
Joakim Karlsson, Lisa M Nilsson, Suman Mitra, Samuel Alsén, Ganesh V Shelke, Vasu R. Sah, Elin Forsberg, Ulrika Stierner, C. All-Eriksson, Berglind Osk Einarsdottir, Henrik Jespersen, Lars Ny, Per Lindnér, Erik Larsson, Roger Olofsson Bagge, Jonas A Nilsson
Nature Communications - 2020 -
Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit
metastasis
Junko Johansson, Roberta Kiffin, Ebru Aydin, Malin S. Nilsson, Kristoffer Hellstrand, Per Lindnér, Peter Naredi, Roger Olofsson Bagge, Anna Martner
Oncoimmunology - 2020 -
The impact of increased immigration to Sweden on the incidence and treatment of patients with HCC and underlying liver
disease
Helena Taflin, Lars-Olof Hafström, Erik Holmberg, Maria Castedal, Per Lindnér
Scandinavian Journal of Gastroenterology - 2019 -
A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver
transplantation
Malin Sternby Eilard, Mats Andersson, Peter Naredi, Charalampos Geronymakis, Per Lindnér, Christian Cahlin, William Bennet, Magnus Rizell
BMC Cancer - 2019 -
Gallbladder cancer - no improvement in survival over time in a Swedish
population
Per Lindnér, Erik Holmberg, Lars-Olof Hafström
Acta Oncologica - 2018 -
Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma
Patients
Junko Johansson, Roberta Kiffin, Annica Andersson, Per Lindnér, Peter Naredi, Roger Olofsson Bagge, Anna Martner
Frontiers in Oncology - 2018 -
The risk of graft loss 5 years after kidney transplantation is increased if cold ischemia time exceeds 14
hours
Josefin Hansson, Lars Mjörnstedt, Per Lindnér
Clinical Transplantation - 2018 -
Staging and therapy for patients with hepatocellular cancer in a defined population from 2000 to 2011 - active palliative treatment improved overall
survival.
Per Lindnér, Erik Holmberg, Magnus Rizell, Larsolof Hafström
Acta oncologica (Stockholm, Sweden) - 2016 -
Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic
Perfusion.
Ilan Ben-Shabat, Valerio Belgrano, Lars Ny, Jonas A Nilsson, Per Lindnér, Roger Olofsson Bagge
Annals of surgical oncology - 2016 -
Erratum to: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled
trial.
Roger Olofsson Bagge, Lars Ny, Charlotta All-Ericsson, Malin Sternby Eilard, Magnus Rizell, Christian Cahlin, Ulrika Stierner, Ulf Lönn, Johan Hansson, Ingrid Ljuslinder, Lotta Lundgren, Gustav Ullenhag, Jens Folke Kiilgaard, Jonas A Nilsson, Per Lindnér
Trials - 2015 -
The impact of changed strategies for patients with cholangiocarcinoma in this
millenium.
Per Lindnér, Magnus Rizell, Lo Hafström
HPB surgery : a world journal of hepatic, pancreatic and biliary surgery - 2015 -
Isolated hepatic perfusion as a treatment for liver metastases of uveal
melanoma.
Ilan Ben-Shabat, Christoffer Hansson, Malin Sternby Eilard, Christian Cahlin, Magnus Rizell, Per Lindnér, Jan Mattsson, Roger Olofsson Bagge
Journal of visualized experiments : JoVE - 2015 -
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled
trial.
Roger Olofsson, Lars Ny, Malin Sternby Eilard, Magnus Rizell, Christian Cahlin, Ulrika Stierner, Ulf Lönn, Johan Hansson, Ingrid Ljuslinder, Lotta Lundgren, Gustav Ullenhag, Jens Folke Kiilgaard, Jonas A Nilsson, Per Lindnér
Trials - 2014 -
Isolated Hepatic Perfusion for Ocular Melanoma Metastasis: Registry Data Suggests a Survival
Benefit.
Roger Olofsson, Christian Cahlin, C All-Ericsson, Farida Hashimi, Jan Mattsson, Magnus Rizell, Per Lindnér
Annals of surgical oncology - 2014 -
MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal
melanoma
Maria Eldh, Roger Olofsson Bagge, Cecilia Lässer, Joar Svanvik, Margareta Sjöstrand, Jan Mattsson, Per Lindnér, Dong-Sic Choi, Yong Song Gho, Jan Lötvall
BMC Cancer - 2014 -
An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after
transplantation.
Jana Ekberg, Henrik Ekberg, Bente Jespersen, Ragnar Källen, Karin Skov, Michael Olausson, Lars Mjörnstedt, Per Lindnér
Transplantation research - 2014 -
Melan-A specific CD8+ T lymphocytes after hyperthermic isolated limb perfusion: A pilot study in patients with in-transit metastases of malignant
melanoma.
Roger Olofsson, Erika Lindberg, Alex Karlsson-Parra, Per Lindnér, Jan Mattsson, Bengt Andersson
International Journal of Hyperthermia - 2013 -
Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant
melanoma.
Roger Olofsson, Jan Mattsson, Per Lindnér
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group - 2013 -
Long-Term Outcome of Isolated Limb Perfusion in Advanced Soft Tissue Sarcoma of the
Extremity.
Peter Bergh, Örjan Berlin, Katarina Engström, Björn Gunterberg, Malin Hansson, Per Lindnér, Jan Mattsson, Roger Olofsson
Annals of surgical oncology - 2012 -
Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular
cancer.
Magnus Rizell, Mats Andersson, Christian Cahlin, Lars-Olof Hafström, Michael Olausson, Per Lindnér
International journal of clinical oncology / Japan Society of Clinical Oncology - 2008 -
Isolated hepatic perfusion for liver metastases of malignant
melanoma.
Magnus Rizell, Jan Mattson, Christian Cahlin, Lars-Olof Hafström, Per Lindnér, Michael Olausson
Melanoma research - 2008 -
Retransplantation of the
liver.
Bengt I. Gustafsson, Lars Bäckman, Styrbjörn Friman, Gustaf Herlenius, Per Lindnér, Lars Mjörnstedt, Michael Olausson
Transplantation proceedings - 2006 -
Extended right-sided liver resection for colorectal liver metastases--impact of percutaneous portal venous
embolisation
Per Lindnér, Christian Cahlin, Styrbjörn Friman, Lars-Olof Hafström, H. Klingenstierna, Lars Lönn, Michael Olausson, M. Rizell
European journal of surgical oncology - 2006 -
Blood flow in liver tumors--effects of vasoactive drugs estimated with xenon (133Xe)
clearance.
Per Lindnér, J Tölli, Peter Naredi, M Oman, Lars-Olof Hafström
Hepato-gastroenterology - 2004 -
A comparison between hepatic artery ligation and portal 5-Fu infusion versus 5-Fu intra arterial infusion for colorectal liver
metastases.
Peter Naredi, M Oman, P-J Blind, Per Lindnér, Bengt Gustavsson, Lars-Olof Hafström
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 2003 -
Monotherapy with histamine dihydrochloride suppresses in vivo growth of a rat sarcoma in liver and
subcutis.
Magnus Rizell, Kristoffer Hellstrand, Per Lindnér, Peter Naredi
Anticancer research - 2002 -
P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver
resection.
Y Yang, Ann Forslund, H Remotti, Christina Lönnroth, M Andersson, Hans Brevinge, Elisabeth Svanberg, Per Lindnér, Lars-Olof Hafström, Peter Naredi, Kent Lundholm
Cancer - 2001 -
Alleviating oxidative stress in cancer immunotherapy: a role for
histamine?
Kristoffer Hellstrand, Mats Brune, Claes Dahlgren, Markus Hansson, Svante Hermodsson, Per Lindnér, Ulf-Henrik Mellqvist, Peter Naredi
Medical oncology (Northwood, London, England) - 2000 -
Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and
melphalan.
Per Lindnér, M Fjälling, Lars-Olof Hafström, H Kierulff-Nielsen, J Mattsson, Tore Scherstén, Magnus Rizell, Peter Naredi
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 1999 -
Treatment of primary liver
cancer.
Lars-Olof Hafström, Peter Naredi, Per Lindnér, Stig B Holmberg, Tore Scherstén
The European journal of surgery = Acta chirurgica - 1998 -
Digitonin enhances the efficacy of carboplatin in liver tumour after intra-arterial
administration.
Per Lindnér, D Heath, S B Howell, Peter Naredi, Lars-Olof Hafström
Cancer chemotherapy and pharmacology - 1997 -
The influence of zymosan and indomethacin on liver and kidney tumor growth. An experimental study in
rats.
M G Ohman, P Blind, Stig B Holmberg, Peter Naredi, Per Lindnér, Lars-Olof Hafström
Journal of experimental & clinical cancer research : CR - 1997 -
Vasopressin modulation of peritoneal, lymphatic, and plasma drug exposure following intraperitoneal
administration.
Per Lindnér, D Heath, S Howell, Peter Naredi, Lars-Olof Hafström
Clinical cancer research : an official journal of the American Association for Cancer Research - 1996 -
Influence of zymosan (a non-specific macrophage stimulator) and of indomethacin on liver tumours--an experimental study in
rats.
Stig B Holmberg, Peter Naredi, Per Lindnér, Ingvar Karlberg, Peter Daneryd, Lilian M. Karlsson, Anders Pettersson, U Stenram, Lars-Olof Hafström
Journal of cancer research and clinical oncology - 1995 -
Influence of hepatic artery occlusion and desferrioxamine on liver-tumour
growth.
Per Lindnér, Peter Naredi, A Peterson, Lars-Olof Hafström
International journal of cancer. Journal international du cancer - 1995 -
Isolated hyperthermic liver perfusion with chemotherapy for liver
malignancy.
Lars-Olof Hafström, Stig B Holmberg, Peter Naredi, Per Lindnér, Anders Bengtsson, G Tidebrant, Tore Scherstén
Surgical oncology - 1994 -
Histamine in immunotherapy of advanced melanoma: a pilot
study.
Kristoffer Hellstrand, Peter Naredi, Per Lindnér, Kent Lundholm, Carl-Magnus Rudenstam, Svante Hermodsson, Mats Asztely, Lars-Olof Hafström
Cancer immunology, immunotherapy : CII - 1994 -
Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the
liver.
Per Lindnér, G Carlsson, Bengt Gustavsson, Stig B Holmberg, Peter Naredi, A Peterson, Lars-Olof Hafström
Anticancer research - 1994 -
Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical
trial.
Lars-Olof Hafström, Boel Engarås, Stig B Holmberg, Bengt Gustavsson, P E Jönsson, Per Lindnér, Peter Naredi, G Tidebrant
Cancer - 1994 -
Hepatic artery occlusion and energy charge in rat liver
tumour.
Per Lindnér, Björn Biber, Bengt Gustavsson, Stig B Holmberg, Peter Naredi, Lars-Olof Hafström
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO - 1994 -
Regional lymphatic drug exposure following intraperitoneal administration of 5-fluorouracil, carboplatin, and
etoposide.
Per Lindnér, D D Heath, D R Shalinsky, S B Howell, Peter Naredi, Lars-Olof Hafström
Surgical oncology - 1993 -
The effects of tumour necrosis factor alpha on the vascular bed and blood flow in an experimental rat
hepatoma.
Peter Naredi, Per Lindnér, Stig B Holmberg, U Stenram, A Peterson, Lars-Olof Hafström
International journal of cancer. Journal international du cancer - 1993 -
The influence of hepatic artery ligation and of vasopressin on liver tumour blood flow in
rats.
Peter Naredi, Per Lindnér, Stig B Holmberg, Rigmor Söderberg, Göran Carlsson, Bengt Gustavsson, Lars Jacobsson, Lars-Olof Hafström
Journal of surgical oncology - 1992 -
Cytotoxicity of liver macrophages against liver tumours. Influence of betamethasone, indomethacin and
allopurinol.
Stig B Holmberg, Per Lindnér, Peter Naredi, Lars-Olof Hafström
Anticancer research - 1991